“Connecting venture capital with scientific excellence”

You’re investing in life sciences, and you need more than a good pitch. You need certainty.

At Bio- and Life Science Consulting, we connect breakthrough science with sound investment. We help you validate that early-stage life-science and technology ventures are built on robust scientific foundations, follow Good Scientific Practices and have the potential to scale into GxP-ready execution to accelerate meaningful innovation in life sciences.

As Featured In:

What We Do

We help venture investors verify that life science & technology start-ups are built on sound methodology, compliant-by-design principles and operational feasibility

Scientific Due Diligence: Evaluate whether scientific foundations are robust, reproducible, and based on a clear, defensible methodology.

Compliance & GxP Readiness: Assess whether current processes, documentation and workflows follow Good Scientific Practice, maintain data integrity and have potential to scale into GxP-relevant environments.

Pitch & Fraud Screening: Go beyond the pitch deck. We dig into data, claims and red-flags to provide an independent, evidence-based assessment: of credibility and technical plausibility.

Gap Resolution Support: Provide clear, science-driven recommendations to address identified gaps, strengthen methodology, and improve readiness for regulated development.

Portfolio Monitoring: Ongoing scientific and operational oversight post-investment and training of Start-Ups in audit preparation.

We specialise in three core domains:

We help venture investors verify that life science & technology start-ups are built on sound methodology, compliant-by-design principles and operational feasibility

Scientific integrity

Reviewing experimental designs, reproducibility, data integrity, publication vs internal data in early-stage pharmaceutical and diagnostics development.

E-compliance

Ensuring that early-stage digital and AI enabled pharma technologies follow clean, traceable and regulation-aligned development practices.

GxP readiness

Assessing whether a product is positioned to scale into GxP environments. We also provide suggestions how a promising start-up can change its processes and methodologies to become GxP ready in due time.

ENSURE THE SCIENCE IS AS STRONG AS THE VISION

In biotech and life sciences, innovation has always moved fast – and AI-enabled technologies are accelerating both the pace and complexity. This creates extraordinary opportunities, but also increases the risk that scientific, operational or governance gaps go unnoticed in early stages, leading to delayed development and sink investments. As an investor, you deserve more than optimism - you deserve clarity and confidence. With our consultancy, you gain a partner who translates complex pharmaceutical development and technologies, into clear investment-relevant insight.

Let’s talk. Schedule a discovery call and we’ll discuss how you can minimise risk and maximise value in your next life-science investment.

Testimonials

“ Proin gravida nibh vel velit auctor aliquet aenean sollicitudin, lorem quis bibendum auctor nisi elit consequat ipsum, nec sagittis sem nibh id elit duis sed odio sit amet nibh vulputate. ”

Christine Walters

My Story

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident.

Sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis.